Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Hoffman

Showing results (21-30 of 204) with videos related to

Pageof 21
Sort By:
Hematology/Oncology Clinics of North America|March 1, 2021
Overview of Myeloproliferative Neoplasms: History, Pathogenesis, Diagnostic Criteria, and ComplicationsDouglas Tremblay, Abdulraheem Yacoub, Ronald Hoffman
Blood|June 16, 2012
Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitorsVikas Gupta, Parameswaran Hari, Ronald Hoffman
Hematology/Oncology Clinics of North America|April 3, 2012
Why does my patient have erythrocytosis?Marina Kremyanskaya, John Mascarenhas, Ronald Hoffman
Annals of the New York Academy of Sciences|June 15, 2019
Ex vivo HSC expansion challenges the paradigm of unidirectional human hematopoiesisLuena Papa, Mansour Djedaini, Ronald Hoffman
Haematologica|July 29, 2021
The possible role of mutated endothelial cells in myeloproliferative neoplasmsMirko Farina, Domenico Russo, Ronald Hoffman
Journal of Visualized Experiments : Jove|April 30, 2019
Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic AcidLuena Papa, Mansour Djedaini, Ronald Hoffman
Expert Opinion on Pharmacotherapy|April 16, 2015
Anagrelide hydrochloride and ruxolitinib for treatment of polycythemia veraMarina Kremyanskaya, John Mascarenhas, Ronald Hoffman
Blood|March 1, 2011
Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cellsPratima Chaurasia, Dmitriy Berenzon, Ronald Hoffman
Expert Review of Anticancer Therapy|March 27, 2018
Current approaches to challenging scenarios in myeloproliferative neoplasmsEran Zimran, Ronald Hoffman, Marina Kremyanskaya
Blood|October 16, 2025
Modulators of the Hepcidin Pathway in Polycythemia Vera and MyelofibrosisMarina Kremyanskaya, Yelena Z Ginzburg, Ronald Hoffman
Pageof 21

Showing results (21-30 of 204) with videos related to

Sort By:
Pageof 21
Hematology/Oncology Clinics of North America|March 1, 2021
Overview of Myeloproliferative Neoplasms: History, Pathogenesis, Diagnostic Criteria, and ComplicationsDouglas Tremblay, Abdulraheem Yacoub, Ronald Hoffman
Blood|June 16, 2012
Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitorsVikas Gupta, Parameswaran Hari, Ronald Hoffman
Hematology/Oncology Clinics of North America|April 3, 2012
Why does my patient have erythrocytosis?Marina Kremyanskaya, John Mascarenhas, Ronald Hoffman
Annals of the New York Academy of Sciences|June 15, 2019
Ex vivo HSC expansion challenges the paradigm of unidirectional human hematopoiesisLuena Papa, Mansour Djedaini, Ronald Hoffman
Haematologica|July 29, 2021
The possible role of mutated endothelial cells in myeloproliferative neoplasmsMirko Farina, Domenico Russo, Ronald Hoffman
Journal of Visualized Experiments : Jove|April 30, 2019
Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic AcidLuena Papa, Mansour Djedaini, Ronald Hoffman
Expert Opinion on Pharmacotherapy|April 16, 2015
Anagrelide hydrochloride and ruxolitinib for treatment of polycythemia veraMarina Kremyanskaya, John Mascarenhas, Ronald Hoffman
Blood|March 1, 2011
Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cellsPratima Chaurasia, Dmitriy Berenzon, Ronald Hoffman
Expert Review of Anticancer Therapy|March 27, 2018
Current approaches to challenging scenarios in myeloproliferative neoplasmsEran Zimran, Ronald Hoffman, Marina Kremyanskaya
Blood|October 16, 2025
Modulators of the Hepcidin Pathway in Polycythemia Vera and MyelofibrosisMarina Kremyanskaya, Yelena Z Ginzburg, Ronald Hoffman
Pageof 21